Literature DB >> 23137999

The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.

Zezhi Li1, Yanxia Zhang, Zuowei Wang, Jun Chen, Jinbo Fan, Yangtai Guan, Chen Zhang, Chengmei Yuan, Wu Hong, Yong Wang, Zhiguo Wu, Jia Huang, Yingyan Hu, Lan Cao, Zhenghui Yi, Donghong Cui, Shunying Yu, Yiru Fang.   

Abstract

BACKGROUND: Although genetic variants may play a key role in development of treatment-resistant depression (TRD), relevant research is scarce.
METHODS: To examine whether the polymorphisms of BDNF (rs6265) and NTRK2 (rs1387923, rs2769605 and rs1565445) genes confer risk for TRD in major depressive disorder (MDD), a total of 948 MDD patients were recruited in a 12-week, multicenter, prospective longitudinal study.
RESULTS: Our study showed a significant allelic association between rs1565445 and TRD with an excess of the T allele in the TRD group, compared to non-TRD group (OR = 1.43, 95%CI: 1.16-1.76, p = 0.0008); while patients with genotype C/C and T/C in rs1565445 were less likely to develop TRD than those carrying T/T (OR = 0.52, 95%CI: 0.33-0.82; OR = 0.72, 95%CI: 0.54-0.97, respectively; p = 0.005). Haplotype T-T (rs1565445 and rs1387923) had 1.41-fold increased risk of TRD (p = 0.0014). Furthermore, significant four-locus (rs1387923-rs1565445-rs2769605-rs6265) gene-gene interactions were detected by the Multifactor-dimensionality reduction (MDR) method. DISCUSSION: These results suggest that the interactions of BDNF (rs6265) with NTRK2 (rs1387923, rs2769605 and rs1565445) gene polymorphisms likely play an essential role in the development of TRD in Han Chinese MDD patients.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137999      PMCID: PMC3584686          DOI: 10.1016/j.jpsychires.2012.10.003

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  44 in total

1.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.

Authors:  M D Ritchie; L W Hahn; N Roodi; L R Bailey; W D Dupont; F F Parl; J H Moore
Journal:  Am J Hum Genet       Date:  2001-06-11       Impact factor: 11.025

2.  A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.

Authors:  Yiru Fang; Chengmei Yuan; Yifeng Xu; Jun Chen; Zhiguo Wu; Lan Cao; Zhenghui Yi; Wu Hong; Yong Wang; Kaida Jiang; Xingjia Cui; Joseph R Calabrese; Keming Gao
Journal:  J Clin Psychopharmacol       Date:  2011-10       Impact factor: 3.153

3.  Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression.

Authors:  Marisa S P Toups; Tracy L Greer; Benji T Kurian; Bruce D Grannemann; Thomas J Carmody; Ryan Huebinger; Chad Rethorst; Madhukar H Trivedi
Journal:  J Psychiatr Res       Date:  2011-10       Impact factor: 4.791

4.  Chronic, treatment-resistant depression and right fronto-striatal atrophy.

Authors:  P J Shah; M F Glabus; G M Goodwin; K P Ebmeier
Journal:  Br J Psychiatry       Date:  2002-05       Impact factor: 9.319

5.  Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis.

Authors:  Thierry Dervieux; Judith A M Wessels; Joel M Kremer; Leonid Padyukov; Maria Seddighzadeh; Saedis Saevarsdottir; Ronald F van Vollenhoven; Lars Klareskog; Tom W Huizinga; Henk-Jan Guchelaar
Journal:  Pharmacogenet Genomics       Date:  2012-01       Impact factor: 2.089

6.  Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study.

Authors:  Zezhi Li; Dake Qi; Jun Chen; Chen Zhang; Zhenghui Yi; Chengmei Yuan; Zuowei Wang; Wu Hong; Shunying Yu; Donghong Cui; Yiru Fang
Journal:  Psychoneuroendocrinology       Date:  2012-06-07       Impact factor: 4.905

7.  Vulnerability to depression: from brain neuroplasticity to identification of biomarkers.

Authors:  Aurélie Blugeot; Cyril Rivat; Elodie Bouvier; Jenny Molet; Amandine Mouchard; Brigitte Zeau; Christophe Bernard; Jean-Jacques Benoliel; Chrystel Becker
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

8.  Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

Authors:  Z Wang; Z Li; J Chen; J Huang; C Yuan; W Hong; S Yu; Y Fang
Journal:  Genes Brain Behav       Date:  2012-05-04       Impact factor: 3.449

9.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

10.  Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.

Authors:  Tommi Saarelainen; Panu Hendolin; Guilherme Lucas; Eija Koponen; Mikko Sairanen; Ewen MacDonald; Karin Agerman; Annakaisa Haapasalo; Hiroyuki Nawa; Raquel Aloyz; Patrik Ernfors; Eero Castrén
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

View more
  19 in total

Review 1.  Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Authors:  Tristram A Lett; Henrik Walter; Eva J Brandl
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

2.  A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Authors:  Chen Zhang; Zezhi Li; Zhiguo Wu; Jun Chen; Zuowei Wang; Daihui Peng; Wu Hong; Chengmei Yuan; Zhen Wang; Shunying Yu; Yifeng Xu; Lin Xu; Zeping Xiao; Yiru Fang
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

Review 3.  The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice.

Authors:  Zhenghua Hou; Wenhao Jiang; Yingying Yin; Zhijun Zhang; Yonggui Yuan
Journal:  Neurosci Bull       Date:  2016-05-30       Impact factor: 5.203

4.  A developmental model of addictions: integrating neurobiological and psychodynamic theories through the lens of attachment.

Authors:  Mauricio Alvarez-Monjaras; Linda C Mayes; Marc N Potenza; Helena Jv Rutherford
Journal:  Attach Hum Dev       Date:  2018-07-18

5.  A kernel regression approach to gene-gene interaction detection for case-control studies.

Authors:  Nicholas B Larson; Daniel J Schaid
Journal:  Genet Epidemiol       Date:  2013-07-19       Impact factor: 2.135

6.  Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression.

Authors:  Guoqing Zhao; Chen Zhang; Jun Chen; Yousong Su; Rubai Zhou; Fan Wang; Weiping Xia; Jia Huang; Zuowei Wang; Yingyan Hu; Lan Cao; Xiaoyun Guo; Chengmei Yuan; Yong Wang; Zhenghui Yi; Weihong Lu; Yan Wu; Zhiguo Wu; Wu Hong; Daihui Peng; Yiru Fang
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

7.  Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression.

Authors:  Wu Hong; Jinbo Fan; Chengmei Yuan; Chen Zhang; Yingyan Hu; Daihui Peng; Yong Wang; Jia Huang; Zezhi Li; Shunying Yu; Xiaohua Liu; Zhiguo Wu; Jun Chen; Zhenghui Yi; Lin Xu; Yiru Fang
Journal:  Neuroreport       Date:  2014-07-09       Impact factor: 1.837

8.  Utility of the Berlin questionnaire for predicting obstructive sleep apnea in individuals with treatment-resistant depression.

Authors:  Michael W Best; Michael Fitzpatrick; Roumen Milev; Christopher R Bowie; Ruzica Jokic
Journal:  Sleep Breath       Date:  2013-04-11       Impact factor: 2.816

9.  The Interaction of TXNIP and AFq1 Genes Increases the Susceptibility of Schizophrenia.

Authors:  Yousong Su; Wenhua Ding; Mengjuan Xing; Dake Qi; Zezhi Li; Donghong Cui
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

Review 10.  Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications.

Authors:  Zezhi Li; Meihua Ruan; Jun Chen; Yiru Fang
Journal:  Neurosci Bull       Date:  2021-02-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.